12 Comments
Oct 24, 2023Liked by Hedley Rees

Nah. I read all the analyst research on these names and the share price has nothing to do with the pending legal shit show I’m afraid.

It’s just that enough of the market was Covid believers (just like everyone else) and now that portion of shareholders is being slapped in the face with the cold, hard reality that a growing chunk of the population think the jabs are a waste of time. Very few know how deadly they are in reality. So sales expectations have dropped. And hence the share price.

The market is a herd, it’s on the turn, but we haven’t reached catastrophic plunge yet.

We are a few years ahead, knowledge wise.

Expand full comment
author

Agree that we aren't seeing the full impact yet. No so sure on your timeline? It could come quicker, given that all the tiers in the supply chain will be feeling the impact. Lonza already sacked their CEO for lowered earning (Moderna drug substance manufacturer): https://www.reuters.com/business/healthcare-pharmaceuticals/lonza-ceo-leave-by-mutual-agreement-2023-09-18/

Expand full comment

But this is just seen as sales guidance failures. Same at Pfizer: they made the poor IR (financial comms) guy take the blame, when I very much doubt it was him that created the terrible guidance. In my experience, commercial teams do a realistic estimate, the CEO demands they deliver more (to make his bonus target, set by board), and a hybrid number gets baked in, agreed by CFO and board and communicated to the street. Then when the company fails to meet it, fingers start pointing. At least at Lonza they pointed to the most culpable.

What I meant by a few years, is that I have been saying since the outset that these products were bad, and that ultimately public opinion would turn and the liability shield would fall. Only now, after 2.5 years of injury and death, are people starting to wake up to how dangerous the injections are. They have known they don’t work since jab no.3, by and large, but the dangers are only just starting to be talked about. I talk to the pharma analysts a lot (used to be one), and nobody was with me at the outset. Now a handful are. These people are close to the data, but were scared by the propaganda like so many others. That fear won’t last indefinitely, then their minds will open - one by one - they will see the damage and start to dig into the legal processes. Remember the companies have to disclose them in their financial reporting. And then it will hit home, when court dates are set and class actions filed.

Case in point: GSK was sued on Zantac historic dangers Sept 2019. The share price didn’t take a hit until August 2022 when an analyst put out a note saying damages could be £40bn, a couple of months before the first court case. The cases need to be timetabled for it to come into focus.

Expand full comment

— H A L L E LU J A H …

!!!!!!!!!!!!!

Expand full comment
founding

Thanks for the good news, Hedley, and congratulations on the second book contract.

Expand full comment
Oct 24, 2023Liked by Hedley Rees

Whoo Hooo! Entire world can use a lot of optimism right now! Unfortunate timing of wars and other distractions makes it difficult to keep eyes on the ball...Thanks!

Expand full comment
author

Keep those eyes peeled....:O)!

Expand full comment

Brilliant. Some goods news at last. Whst a fabulous Xmas treat of one of these companies went broke.

Expand full comment
author

There's a guy with a long white beard fulfiling your wishes as we speak, me thinks...

Expand full comment

I predicted this would happen

Since the IOJ case got accepted into the courts in Costa Rica and some bloke in America sueing Pfizer for $35million so much has come out and every single day am reading more from people escaping the imminent collapse of big pharma

The fallout and prosecutions needs to be from the very top to every community GP / pharmacy or they'll have beaten the system

Expand full comment

Congrats on your new book deal. Going bust won't help those killed or maimed and a lot of those big investors, including CEO's have already sold shares when prices high. I wonder if UK gov already handed over dosh to Moderna and will we get it back?

Expand full comment

Nice one on the new book - I shall look forward to having a read as and when available 😊

Expand full comment